NASDAQ:NLTX
Delisted

Neoleukin Therapeutics Stock News

etoro logo Buy NLTX
*Your capital is at risk
$3.49
+0 (+0%)
At Close: Mar 15, 2024
Gold exploration and development company Novo Resources (TSXV:NVO) has launched its campaign on the Investing News Network.
This week could see up to nine companies price their IPOs. Here is a look at the companies looking to go public this week. Codiak Biosciences: Clinical stage...
Oct 09, 2020 (The Expresswire) -- Global “Monoclonal Antibodies market” competitive landscape provides particulars and data information by players. The...
Trust Co. of Oklahoma purchased a new stake in shares of Novo Nordisk A/S (NYSE:NVO) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The in
European stocks rise on upbeat forecasts from Pandora, Novo Nordisk
Novo Nordisk A/S raised its outlook for full-year sales and profit as the Danish drugmaker weathers disruption from COVID-19 and experiences better-than-expected demand for its diabetes medicines.
Oct 08, 2020 (The Expresswire) -- Global “Recombinant Protein Market” report gives a historical overview of the Recombinant Protein market trends, growth,...
Novo Resources Corp. (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that mapping and surface rock sampling indicate the possibility of considerable extensions of the Beatons Creek conglomerate gol
Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that mapping and surface rock sampling indicate the possibility
BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE